Amidst the tumultuous legal whirlwind, Mark Crossley, the indomitable CEO of Indivior, conveyed his sentiments in a statement that resounded with determination. “We are pleased to achieve this settlement to conclude this legacy multidistrict antitrust matter,” he declared. “The resolution of this litigation, which was filed over a decade ago, provides greater certainty for all Indivior stakeholders and allows us to continue focusing on our important work for patients suffering from opioid use disorder and mental health illnesses around the world.”
